OTCMKTS:LNDZF Evome Medical Technologies (LNDZF) Stock Price, News & Analysis $0.01 -0.05 (-81.33%) As of 03/31/2025 09:32 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock About Evome Medical Technologies Stock (OTCMKTS:LNDZF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LNDZF alerts:Sign Up Key Stats Today's Range$0.01▼$0.0550-Day Range$0.01▼$0.0952-Week Range$0.01▼$0.21Volume25,000 shsAverage Volume53,346 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEvome Medical Technologies Inc., through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.Read More… Remove Ads Receive LNDZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address LNDZF Stock News HeadlinesEvome Medical Technologies Provides Market UpdateMarch 28, 2025 | financialpost.comEvome Medical Technologies Provides Market UpdateMarch 28, 2025 | globenewswire.comRevealed: The Chip Stock Redefining AI as We Know ItIn this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech firm poised to disrupt the $1 trillion semiconductor industry. He's the same expert who spotted Apple before the iPhone, Amazon before it dominated retail, and Google before it became a verb. Back then, Wall Street shrugged. They're doing it again—ignoring his latest prediction. But according to his research, what we've seen from AI so far is just the beginning. The real boom is still ahead.April 1, 2025 | InvestorPlace (Ad)Evome Medical Technologies Expands Board, Appoints New ChairmanMarch 17, 2025 | tipranks.comEvome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to SixMarch 17, 2025 | globenewswire.comCLARIFICATION: Evome Medical Technologies Announces Significant Debt RestructuringFebruary 11, 2025 | globenewswire.comEvome Medical Technologies Reduces Debt, Enhances Financial FlexibilityFebruary 10, 2025 | tipranks.comEvome Medical Technologies Announces Significant Debt Reduction and RestructuringFebruary 10, 2025 | globenewswire.comSee More Headlines LNDZF Stock Analysis - Frequently Asked Questions How have LNDZF shares performed this year? Evome Medical Technologies' stock was trading at $0.06 on January 1st, 2025. Since then, LNDZF shares have decreased by 81.3% and is now trading at $0.0112. View the best growth stocks for 2025 here. How do I buy shares of Evome Medical Technologies? Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today4/01/2025Next Earnings (Estimated)5/07/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryMedical Equipment Current SymbolOTCMKTS:LNDZF CIK1617765 Webwww.inspirafin.ca Phone(800) 760-6826FaxN/AEmployees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:LNDZF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evome Medical Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evome Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
